semaglutide injection baton rouge Novo Nordisk launched an oral version of its GLP-1 injectable to US markets on Jan 5. Link in comments Louisiana doctors answer big questions

Nat Commun 15(1):5912 Mosterd CM, Bjornstad P, van Raalte DH (2020) Nephroprotective effects of GLP-1 receptor agonists: where do we stand

Question 1: what is the specific mechanism

Researchers have designed Retatrutide to target: GLP-1 (Glucagon-Like Peptide-1) receptor GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor Glucagon receptor Because these signaling pathways are closely involved in metabolic regulation, scientists continue investigating how simultaneous receptor activation influences biological responses

Metabolic and Body Composition Reaching and maintaining a healthy body composition can positively influence overall wellness